Oragenics, Inc.

Latest News

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

On the Cutting Edge

We are developing medical technologies that solve unmet clinical needs and have a substantial market opportunity

Learn More

Sign up for email updates

Be the first to receive breaking news

Sign Up
NYSE American OGEN
Price Loading...
Change Loading...
Day Range Loading...
52 Wk Range Loading...

Last Updated: